Filter
Period
Filter by
recent search
Showing: 1 – 05 of 53 Regulated Information
–
06 June 2023
06 June 2023
IPSEN – Buy-back programme – Art 5 of MAR – Week 22 – 2023
Aggregated presentation by day and by market
–
01 June 2023
01 June 2023
LinkedIn
Twitter
Facebook
–
01 June 2023
01 June 2023
LinkedIn
Combined Shareholders’ Meeting of Ipsen S.A. held on 31 May 2023
REGULATED INFORMATION
–
31 May 2023
31 May 2023
LinkedIn
Description of the regulatory framework of the share repurchase program to be approved at the Combined Shareholders’ Meeting on 31 May 2023
Boulogne-Billancourt (France), on 31 May 2023 – In accordance with the provisions of Article L.22-10-62 et seq. of the French Commercial Code, the European Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April
–
26 May 2023
26 May 2023
LinkedIn
Ipsen receives CHMP negative opinion, following re-examination of potential first FOP treatment in the E.U.
PARIS, FRANCE, 26 May 2023 – Ipsen (Euronext: IPN; ADR: IPSEY) announced today that the re-examination of palovarotene as a potential treatment for the ultra-rare bone disease, fibrodysplasia ossificans progressiva, by the Committee for Medicinal Product